Difference between revisions of "WSI24-422-Case-7"

From MGH Learn Pathology
 
Line 26: Line 26:
 
|frames=1
 
|frames=1
 
|status=completed
 
|status=completed
 +
|reasonCode=HER2 IHC
 
|view=show
 
|view=show
 
|identifier=d8a779a4-d440-459a-8929-4de810bad262
 
|identifier=d8a779a4-d440-459a-8929-4de810bad262
Line 34: Line 35:
 
|frames=2
 
|frames=2
 
|status=completed
 
|status=completed
 +
|reasonCode=HER2 IHC
 
|view=show
 
|view=show
 
|identifier=92e2bded-f471-4cde-b508-22d5cdd9e7ce
 
|identifier=92e2bded-f471-4cde-b508-22d5cdd9e7ce
Line 42: Line 44:
 
|frames=3
 
|frames=3
 
|status=completed
 
|status=completed
 +
|reasonCode=H&E
 
|view=show
 
|view=show
 
|identifier=9e798778-72c8-4dcb-aeba-76d525879323
 
|identifier=9e798778-72c8-4dcb-aeba-76d525879323

Latest revision as of 15:13, February 3, 2026

WSI24-422-Case-7
62 yo F with invasive lobular carcinoma (Slide 1: HER2 IHC from OSH, Slide 2: MGH HER2)
HER2 IHC: 2+ (OSH: 3+) / HER2 FISH: Not amplified (Ratio = 1.9, 3.3/1.7, Group 5)
February 6, 2026 2:00:00 PM